Cite
MLA Citation
Srdan Verstovsek et al.. “Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.” Lancet, vol. 401, no. 10373, 2023, pp. 269–280. http://access.bl.uk/ark:/81055/vdc_100176195803.0x000043